載入中
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
收盤時
US$4.23
+US$0.23 · +5.75%
盤後
US$4.25
+US$0.02 · +0.47%
10月13日 下午4:30 ET
盤中時間採用ET。市場資料可能有所延遲。
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
日內區間
目前US$4.23
52週區間
目前US$4.23
盤中時間採用ET。市場資料可能有所延遲。
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
日內區間
目前US$4.23
52週區間
目前US$4.23
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$20.00
上漲空間 372.81%報告持有此股票曝險的交易所交易基金。
iShares Russell 2000 ETFIWM606.04萬0.01%787.4億 USD0.19%US$276.71-0.43%
Vanguard Extended Market ETFVXF418.76萬0.00%954億 USD0.05%US$232.54-0.42%
iShares Russell 2000 Growth ETFIWO220.6萬0.02%139.17億 USD0.24%US$351.1-0.74%
Vanguard Russell 2000 ETFVTWO187.58萬0.01%180億 USD0.06%US$111.77-0.45%
iShares Micro-Cap ETFIWC73.82萬0.06%13.17億 USD0.60%US$179.6-1.13%
ALPS Medical Breakthroughs ETFSBIO48.32萬0.26%1.87億 USD0.50%US$51.64-4.10%
Vanguard Russell 2000 Growth ETFVTWG35.46萬0.02%17億 USD0.06%US$256.21-0.80%
iShares Russell 2500 ETFSMMD13.15萬0.00%40.62億 USD0.23%US$85.85-0.19%iShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCALPS Medical Breakthroughs ETFSBIOVanguard Russell 2000 Growth ETFVTWGiShares Russell 2500 ETFSMMDAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
